Skip to main content
. 2017 Feb 10;2017(2):CD012066. doi: 10.1002/14651858.CD012066.pub2

1.3. Analysis.

1.3

Comparison 1 Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS), Outcome 3 St. George's Respiratory Questionnaire (SGRQ) total score change from the baseline (mean difference).